Skip to main content
Clinical Trials/JPRN-UMIN000004026
JPRN-UMIN000004026
Completed
Phase 2

A quantification of circulating tumor cells in patients with gastric cancer by telomerase-specific oncolytic adenoviral agents - A quantification of circulating tumor cells in gastric cancer patients by telomerase-specific oncolytic adenoviral agents

Digestive Disease Center, Showa University Nothern Yokohama Hospital0 sites200 target enrollmentAugust 10, 2010

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Digestive Disease Center, Showa University Nothern Yokohama Hospital
Enrollment
200
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 10, 2010
End Date
March 1, 2017
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Digestive Disease Center, Showa University Nothern Yokohama Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)Synchronous or metachronous malignancy. 2\)Pregnant women. 3\)Breast\-feeding women. 4\)Active or chronic viral hepatitis. 5\)Active bacterial or fungous infection. 6\)Diabetes mellitus. 7\)Systemic administration of corticosteroids. 8\)Unstable hypertension.

Outcomes

Primary Outcomes

Not specified

Similar Trials